BioSpace News Archive

BioMidwest

NantOmics to Report Data on Cardiac Function in Sarcoma Patients Receiving Aldoxorubicin with Doxorubicin Equivalent Doses over 1000 mg/m2 at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

NantOmics, LLC will present data on cardiac function in patients treated with aldoxorubicin in combination with Doxorubicin during the sarcoma session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

June 2, 2018
·
2 min read
Drug Development

Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2018 ASCO Annual Meeting

Puma Biotechnology, Inc. announced that interim results from the Phase Ib/II FB-10 clinical trial of Puma’s investigational drug PB272 (neratinib) given in combination with the antibody drug conjugate T-DM1 (Kadcyla, ado-trastuzumab emtansine) were presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

June 2, 2018
·
7 min read
Drug Development

Tesetaxel, Administered Orally as a Single Agent, Results in 45% Confirmed Response Rate in Patients with HER2 Negative, Hormone Receptor Positive, Metastatic Breast Cancer

Odonate Therapeutics, Inc. announced that results from a multicenter Phase 2 study of tesetaxel.

June 2, 2018
·
5 min read
Global Spirometer Market| Growth Analysis and Forecast| Technavio

Market research firm Technavio has announced the release of their latest report on the global spirometer market. This new report will provide expert market insights for the forecast period 2018-2022.

June 2, 2018
·
3 min read
BioForest

S.A.F.E. Project US Invests in Law Enforcement Training for Opioid Response

This week, justice and recovery professionals fighting the nation’s battle against the opioid epidemic have convened in Houston for the National Association of Drug Court Professionals (NADCP) annual conference.

June 2, 2018
·
2 min read
BioMidwest

NantOmics to Present Potential Treatment Options for SCLC Patients with Multiplexed Clinical Proteomic Testing at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

NantOmics, LLC will present findings on potential treatment options for small-cell lung cancer (SCLC) patients with multiplexed clinical proteomic testing during the lung cancer.

June 2, 2018
·
3 min read
BioMidwest

NantOmics to Present Results of DESMOPAZ Study from French Sarcoma Group (FSG) at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

NantOmics, LLC will present findings on how pazopanib (PZ) has meaningful clinical activity in patients with progressive desmoid tumors (DT) during the sarcoma session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting.

June 2, 2018
·
2 min read
BioMidwest

NantHealth and NantOmics to Share Data on Next-Generation Sequencing of Paired DNA and RNA Analysis of Rare Tumors at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

NantHealth, Inc. and and NantOmics, will present data on next-generation sequencing of paired DNA and RNA analysis in patients with rare and ultra-rare cancers during the tumor biology session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting.

June 2, 2018
·
3 min read
Drug Development

Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Reduced the Risk of Disease Worsening or Death for People with Advanced Squamous Non-Small Cell Lung Cancer

Genentech announced that results from the Phase III IMpower131 study showed TECENTRIQ® (atezolizumab) plus chemotherapy (carboplatin and ABRAXANE® [albumin-bound paclitaxel; nab-paclitaxel]).

June 2, 2018
·
12 min read
Natural Partners and Fullscript plan to merge to create the industry-leading, technology-enabled, wellness management service for integrative healthcare practitioners and patients

Natural Partners, Inc. and Fullscript announced plans to combine, bringing the best wholesale and fulfillment network in the nutritional supplement industry together with the premier online supplement dispensing platform.

June 2, 2018
·
3 min read